Align Technology, Inc.(ALGN)

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Latest News & Analysis
Align Technology: Q4 Earnings, Turkey Expansion, and Digital Orthodontics Strategy
Comprehensive analysis of ALGN's Q4 2024 earnings, Turkey launch, and market trends that guide investor decisions.
Align Technology Announces Major Business Developments | Latest Industry News
Align Technology faces market challenges amid strategic expansions. Q4 earnings mixed, Q1 revenue forecasts downbeat, and Turkey launch analyzed.
Align Technology: Q4 Earnings, Turkey Expansion, and 2025 Outlook
Align Technology faces mixed market signals amid Q4 2024 earnings, Turkey expansion, and analyst ratings. Key insights into ALGN's strategy and challenges.
Align Technology (ALGN): Navigating Growth and Challenges in 2025
Align Technology navigates a complex 2025 with earnings, market shifts, and strategic expansions. Key insights for investors and industry professionals.
Align Technology (ALGN) Analysis: Q4 Earnings, Turkey Expansion, and Market Trends
Align Technology (ALGN) navigates mixed signals: earnings beat, revenue miss, Turkey expansion, and teen market challenges. HFD partnership aims to boost affordability.
Align Technology (ALGN) Q4 Earnings: Challenges and Opportunities
Align Technology's Q4 earnings reveal a mixed performance amid market headwinds. Strategic initiatives and analyst optimism offer a path forward.
Align Technology (ALGN): iTero Lumina, Turkey Expansion, and Market Outlook
Align Technology (ALGN) navigates 2025 with innovations like iTero Lumina, Turkey expansion, and strategic partnerships, positioning it for long-term growth amidst challenges.
Align Technology [ALGN]: AI, Market Expansion, and Challenges
Align Technology [ALGN] navigates dental market with AI, iTero Lumina enhancements, and expansion. Q4 revenue miss raises concerns. Clear aligner market faces pressures.
Align Technology (ALGN): AI, Expansion & Stock Analysis
Analysis of Align Technology's AI innovation, market expansion, and stock performance. Includes insights on Align X-ray, iTero Lumina, HFD partnership, and competitive landscape.
Align Technology (ALGN): AI Innovation, Market Analysis & Growth 2025
In-depth analysis of Align Technology's AI innovations, market strategies, and financial outlook for 2025. Explore growth drivers, challenges, and competitive positioning.
Align Technology (ALGN): Investor Day, Innovation, and Market Analysis
Align Technology faces market volatility despite innovative product launches. Investor Day insights, Invisalign advancements, and AI diagnostics shape future strategy.
Align Technology (ALGN): China Approval & Pediatric Growth Drive Outlook
Align Technology secures NMPA approval in China, launching a major pediatric campaign and investing in AI research, signaling robust strategic growth.
Align Technology (ALGN) Unlocks China Market with Key Regulatory Approval
Align Technology's recent NMPA approval in China unlocks vast pediatric market potential. Analysis covers financial performance, strategic moves, and market impact.
Align Technology (ALGN): Digital Platform Key to Unlocking Valuation
Align Technology's strategic pivot towards digital dentistry, marked by robust iTero and exocad integration, aims to unlock premium valuation despite clear aligner ASP pressures.
Align Technology (ALGN) Strategic Digital Pivot Drives Growth Amid Competitive Pressures
Align Technology’s strategic shift to a digital platform combining Invisalign, iTero scanners, and AI integration is shaping future growth and market positioning.
Align Technology Inc: Deep Dive into Digital Transformation and Financial Resilience
Align Technology advances its digital dentistry platform, leveraging Invisalign and iTero to drive growth amid evolving market dynamics and robust financials.
Align Technology's Digital Dentistry Pivot and Q2 Earnings Insights | Monexa AI
Align Technology advances its digital dentistry platform with AI integration, APAC expansion, and strategic board appointments ahead of Q2 2025 earnings.
Align Technology (ALGN) Market Analysis: Digital Dentistry Growth & Financial Insights
Detailed analysis of Align Technology's digital dentistry platform evolution, financial performance, and competitive positioning as of mid-2025.
Align Technology, Inc. (ALGN) Strategic Growth and Q2 2025 Earnings Preview
Detailed analysis of Align Technology's strategic India expansion, product innovations, and Q2 2025 financial outlook with key financial metrics and competitive insights.
Align Technology’s Invisalign Class II Expansion Drives Growth and Market Leadership | ALGN Analysis
Align Technology advances with Invisalign Class II expansion and international growth, reinforcing market leadership and delivering strong financial momentum.
Align Technology Inc. (ALGN) Q2 2025 Analysis: Invisalign Growth and Digital Expansion Drive Financial Momentum
Align Technology's Q2 2025 performance is propelled by Invisalign volume growth, product innovation, and digital dentistry expansion amid FX challenges.
Align Technology Inc Q2 Earnings Miss, Strategic Restructuring, and Market Impact Analysis
In-depth analysis of Align Technology's Q2 earnings miss, strategic restructuring, and financial performance amid economic headwinds and competitive pressures.
Align Technology, Inc. (ALGN) Legal Challenges and Strategic Restructuring: A Data-Driven Market Analysis
Align Technology faces SEC investigation amid Q2 revenue decline; CEO stock purchase signals confidence. Analysis covers financial health, restructuring, and competitive positioning.
Align Technology (ALGN) Q2 Earnings Miss, Legal Investigations, and Strategic Restructuring Impact
Align Technology faces earnings miss, securities investigations, and strategic restructuring amid competitive pressures and macroeconomic headwinds.
Align Technology (ALGN): Q2 Shock, $150–170M Reset, and the Cash-Rich But Credibility-Challenged Backdrop
Align reported Q2 revenue $1.012B and GAAP EPS $2.49 (miss vs. $2.57 est.), announced $150–$170M restructuring, and saw shares plunge ~37%—a liquidity-strong company facing demand and legal tests.
Align Technology (ALGN): Q2 Shock, Guidance Cut and Financial Fallout
A 37% one‑day selloff after Q2 2025 revenue of $1.01B, a $150–$170M restructuring and multiple securities probes shifted the ALGN risk profile.
Align Technology (ALGN): Q2 Shock, Investor Probes and the Financial Ripples
A July Q2 shock—revenue and EPS misses that sent shares down ~37%—has spawned multiple investor probes and forced a costly restructuring. Here’s the financial and strategic read-through.